ECSP972332A - DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE - Google Patents

DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE

Info

Publication number
ECSP972332A
ECSP972332A ECSP972332A ECSP972332A EC SP972332 A ECSP972332 A EC SP972332A EC SP972332 A ECSP972332 A EC SP972332A EC SP972332 A ECSP972332 A EC SP972332A
Authority
EC
Ecuador
Prior art keywords
derivatives
phenylpiridyl
amine
disorders
pyridin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Lowe John Adams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972332 priority Critical patent/ECSP972332A/en
Publication of ECSP972332A publication Critical patent/ECSP972332A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de 6-fenil -piridin-2-ilamina de fórmula (gráfico), en la que G, R1 y R2 se definen en la memoria descriptiva, que presentan actividad como inhibidores de la óxido nítrico sintetasa (NOS), a composiciones farmacéuticas que contienen y a su uso en el tratamiento y prevención de trastornos del sistema nervioso central y otros trastornos.The present invention relates to 6-phenyl-pyridin-2-ylamine derivatives of formula (graph), in which G, R1 and R2 are defined in the specification, which have activity as inhibitors of nitric oxide synthetase (NOS ), to pharmaceutical compositions containing and to their use in the treatment and prevention of disorders of the central nervous system and other disorders.

ECSP972332 1997-12-04 1997-12-04 DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE ECSP972332A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972332 ECSP972332A (en) 1997-12-04 1997-12-04 DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972332 ECSP972332A (en) 1997-12-04 1997-12-04 DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE

Publications (1)

Publication Number Publication Date
ECSP972332A true ECSP972332A (en) 1998-12-14

Family

ID=42043161

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972332 ECSP972332A (en) 1997-12-04 1997-12-04 DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE

Country Status (1)

Country Link
EC (1) ECSP972332A (en)

Similar Documents

Publication Publication Date Title
UY24799A1 (en) 6-PHENYLPIRIDYL-2-AMINE DERIVATIVES
PA8456901A1 (en) 2-AMINOPYRIDINES CONTAINING SUBSTITUTES FOR CONDENSED RINGS
PA8446301A1 (en) 2-AMINO-6- (4-PHENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED
YU12097A (en) 6-phenilpyridyl-2-amine derivatives
BR0314393A (en) Heterocyclic Substituted Piperazines for the Treatment of Schizophrenia
PA8458301A1 (en) 2-AMINOPYRIDIDS WITH BRANCHED ALCOXY SUBSTITUTES
AR028705A1 (en) BIS-ARILSULPHONES
DE60001586D1 (en) DIPHENYL-PIPERIDINE DERIVATIVES
PA8487701A1 (en) DERIVATIVES OF 3,3-BIARYLIPIPERIDINE AND 2,2-BIARYLMORPHOLINE
HN2000000016A (en) 2-AMINOPIRIDINS CONTAINING SUBSTITUTES OF CONDENSED RING TYPE
BR0112131A (en) Pharmaceutical Compositions and Methods for Use
ECSP972332A (en) DERIVATIVES OF 6-PHENYLPIRIDYL -2-AMINE
BR0000901A (en) 4-phenyl-4-heteroarylpiperidine derivatives
YU73200A (en) 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
ECSP982640A (en) 2- AMINOPYRINES WITH BRANCHED ALCOXY SUBSTITUTES
BR0315809A (en) Oxindole-Substituted Piperazine Derivatives
ECSP972056A (en) 6-PHENYLPIRIDYL-2-AMINE DERIVATIVES
ECSP982642A (en) 2 -AMINOPYRIDINES CONTAINING CONDENSED RING SUBSTITUTES
ECSP982405A (en) 2- AMINO-6 (4- PHENOXI -2-SUBSTITUTED) - SUBSTITUTED PIRIDINES
GT199700142A (en) 6-PHENYLPIRIDYL-2-AMINE DERIVATIVES.
ECSP993220A (en) DERIVATIVES OF 3,3- BIARILPIPERIDINA AND 2,2 - BIARILMORFOLINA
ECSP961863A (en) PHARMACOLOGICALLY ACTIVE COMPOUND
ECSP972152A (en) COMPOUNDS THAT HAVE PHARMACOLOGICAL ACTIVITY, PROCEDURES FOR THEIR PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM